HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORENITRAM® safely and effectively. See Full Prescribing Information for ORENITRAM. --------------------- DOSAGE FO

First Page		Document Content
Date: 2016-07-27 09:02:55 Chemistry Organic chemistry GABAA receptor positive allosteric modulators Alcohols Prostaglandins Treprostinil Sodium channel blockers Lorazepam Niacin Riociguat Gemigliptin		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORENITRAM® safely and effectively. See Full Prescribing Information for ORENITRAM. --------------------- DOSAGE FO Add to Reading List Source URL: www.orenitram.com Download Document from Source Website File Size: 4,43 MB Share Document on Facebook

	Beilage 1: Arzneimittelmonographien DocID: 1rinj - View Document
	Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform DocID: 1reFq - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORENITRAM® safely and effectively. See Full Prescribing Information for ORENITRAM. --------------------- DOSAGE FO DocID: 1rcHl - View Document
	Strensiq, INN-asfotase alfa DocID: 1rcrc - View Document
	Microsoft Word - CINRYZE.Product Monographdoc DocID: 1qE2h - View Document